COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADC THERAPEUTICS SA | SHS | H0036K147 | 1,500,191 | 474,744 | SH | | SOLE | | 474,744 | 0 | 0 |
AEROVATE THERAPEUTICS INC | COM | 008064107 | 332,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
ALKERMES PLC | SHS | G01767105 | 15,665,000 | 650,000 | SH | | SOLE | | 650,000 | 0 | 0 |
ALNYLAM PHARMACEUTICALS INC | NOTE 1.000% 9/1 | 02043QAB3 | 16,200,000 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 603,000 | 100,000 | SH | Call | SOLE | | 100,000 | 0 | 0 |
APOGEE THERAPEUTICS INC | COM | 03770N101 | 32,907,736 | 836,283 | SH | | SOLE | | 836,283 | 0 | 0 |
ARCA BIOPHARMA INC | COM | 00211Y506 | 277,614 | 72,484 | SH | | SOLE | | 72,484 | 0 | 0 |
ARCELLX INC | COMMON STOCK | 03940C100 | 25,387,400 | 460,000 | SH | | SOLE | | 460,000 | 0 | 0 |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 1,299,500 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,529,910 | 133,500 | SH | | SOLE | | 133,500 | 0 | 0 |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 8,878,015 | 975,606 | SH | | SOLE | | 975,606 | 0 | 0 |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 14,964,000 | 4,300,000 | SH | | SOLE | | 4,300,000 | 0 | 0 |
AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 561,150 | 45,000 | SH | | SOLE | | 45,000 | 0 | 0 |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,440,000 | 80,000 | SH | | SOLE | | 80,000 | 0 | 0 |
BEIGENE LTD | SPONSORED ADR | 07725L102 | 15,693,700 | 110,000 | SH | | SOLE | | 110,000 | 0 | 0 |
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 3,029,000 | 650,000 | SH | | SOLE | | 650,000 | 0 | 0 |
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 17,256,850 | 17,000,000 | PRN | | SOLE | | 17,000,000 | 0 | 0 |
BRIDGEBIO PHARMA INC | COM | 10806X102 | 2,533,000 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 17,594,554 | 475,400 | SH | | SOLE | | 475,400 | 0 | 0 |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 10,255,389 | 1,135,702 | SH | | SOLE | | 1,135,702 | 0 | 0 |
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 20,445,000 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 10,222,500 | 250,000 | SH | Call | SOLE | | 250,000 | 0 | 0 |
COHERUS BIOSCIENCES INC | NOTE 1.500% 4/1 | 19249HAB9 | 8,636,281 | 11,750,000 | PRN | | SOLE | | 11,750,000 | 0 | 0 |
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 3,023,092 | 500,512 | SH | | SOLE | | 500,512 | 0 | 0 |
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 3,246,376 | 1,619,140 | SH | | SOLE | | 1,619,140 | 0 | 0 |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 23,066,850 | 515,000 | SH | | SOLE | | 515,000 | 0 | 0 |
CULLINAN THERAPEUTICS INC | COM | 230031106 | 4,600,968 | 263,817 | SH | | SOLE | | 263,817 | 0 | 0 |
DYNE THERAPEUTICS INC | COM | 26818M108 | 3,529,000 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
ELEVATION ONCOLOGY INC | COM | 28623U101 | 3,965,828 | 1,468,825 | SH | | SOLE | | 1,468,825 | 0 | 0 |
ELIEM THERAPEUTICS INC | COM | 28658R106 | 11,878,400 | 1,670,661 | SH | | SOLE | | 1,670,661 | 0 | 0 |
ERASCA INC | COM | 29479A108 | 5,898,657 | 2,499,431 | SH | | SOLE | | 2,499,431 | 0 | 0 |
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 10,151,614 | 223,407 | SH | | SOLE | | 223,407 | 0 | 0 |
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,550,000 | 250,000 | SH | Call | SOLE | | 250,000 | 0 | 0 |
GENELUX CORPORATION | COM | 36870H103 | 195,000 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
GERON CORP | COM | 374163103 | 6,360,000 | 1,500,000 | SH | | SOLE | | 1,500,000 | 0 | 0 |
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 2,555,000 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
HILLEVAX INC | COM | 43157M102 | 3,844,321 | 265,859 | SH | | SOLE | | 265,859 | 0 | 0 |
IMMATICS N.V | SHS | N44445109 | 3,486,000 | 300,000 | SH | | SOLE | | 300,000 | 0 | 0 |
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 484,858 | 187,204 | SH | | SOLE | | 187,204 | 0 | 0 |
IMMUNOVANT INC | COM | 45258J102 | 9,136,723 | 346,088 | SH | | SOLE | | 346,088 | 0 | 0 |
IMMUNOVANT INC | COM | 45258J102 | 1,433,520 | 54,300 | SH | Call | SOLE | | 54,300 | 0 | 0 |
INARI MED INC | COM | 45332Y109 | 9,630,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
INOZYME PHARMA INC | COM | 45790W108 | 12,738,884 | 2,856,252 | SH | | SOLE | | 2,856,252 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 8,375,000 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 582,900 | 8,700 | SH | Put | SOLE | | 8,700 | 0 | 0 |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,203,000 | 150,000 | SH | Put | SOLE | | 150,000 | 0 | 0 |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 802 | 100 | SH | | SOLE | | 100 | 0 | 0 |
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 6,296,453 | 9,750,000 | PRN | | SOLE | | 9,750,000 | 0 | 0 |
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 1,057,067 | 1,761,778 | SH | | SOLE | | 1,761,778 | 0 | 0 |
KURA ONCOLOGY INC | COM | 50127T109 | 13,383,500 | 650,000 | SH | | SOLE | | 650,000 | 0 | 0 |
KYVERNA THERAPEUTICS INC | COM | 501976104 | 1,500,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 30,817,600 | 110,000 | SH | | SOLE | | 110,000 | 0 | 0 |
MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,541,670 | 767,000 | SH | | SOLE | | 767,000 | 0 | 0 |
MERUS N V | COM | N5749R100 | 7,396,250 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
MINERALYS THERAPEUTICS INC | COM | 603170101 | 3,837,120 | 327,959 | SH | | SOLE | | 327,959 | 0 | 0 |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 5,299,450 | 155,000 | SH | | SOLE | | 155,000 | 0 | 0 |
MORPHIC HLDG INC | COM | 61775R105 | 8,537,022 | 250,573 | SH | | SOLE | | 250,573 | 0 | 0 |
NEUROBO PHARMACEUTICALS IN | COM | 64132R404 | 431,834 | 89,222 | SH | | SOLE | | 89,222 | 0 | 0 |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 8,128,808 | 423,155 | SH | | SOLE | | 423,155 | 0 | 0 |
NEWAMSTERDAM PHARMA COMPANY | *W EXP 99/99/999 | N62509117 | 1,916,587 | 202,599 | SH | | SOLE | | 202,599 | 0 | 0 |
NEXTCURE INC | COM | 65343E108 | 2,683,848 | 1,687,955 | SH | | SOLE | | 1,687,955 | 0 | 0 |
NKARTA INC | COM | 65487U108 | 1,182,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
NURIX THERAPEUTICS INC | COM | 67080M103 | 19,033,440 | 912,000 | SH | | SOLE | | 912,000 | 0 | 0 |
NUVALENT INC | COM | 670703107 | 15,172,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 2,975,500 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
OMEROS CORP | NOTE 5.250% 2/1 | 682143AG7 | 8,083,023 | 11,450,000 | PRN | | SOLE | | 11,450,000 | 0 | 0 |
PASSAGE BIO INC | COM | 702712100 | 209,880 | 264,266 | SH | | SOLE | | 264,266 | 0 | 0 |
PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | 3,521,000 | 350,000 | SH | | SOLE | | 350,000 | 0 | 0 |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 5,483,500 | 550,000 | SH | | SOLE | | 550,000 | 0 | 0 |
PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 398,937 | 265,958 | SH | | SOLE | | 265,958 | 0 | 0 |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 815,000 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Q32 BIO INC | COM | 746964105 | 498,597 | 27,777 | SH | | SOLE | | 27,777 | 0 | 0 |
RAPT THERAPEUTICS INC | COM | 75382E109 | 1,662,250 | 545,000 | SH | Put | SOLE | | 545,000 | 0 | 0 |
RAPT THERAPEUTICS INC | COM | 75382E109 | 228,750 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
REZOLUTE INC | COM NEW | 76200L309 | 7,955,000 | 1,850,000 | SH | | SOLE | | 1,850,000 | 0 | 0 |
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 4,523 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
ROIVANT SCIENCES LTD | SHS | G76279101 | 3,716,275 | 351,587 | SH | | SOLE | | 351,587 | 0 | 0 |
SANA BIOTECHNOLOGY INC | COM | 799566104 | 2,844,660 | 521,000 | SH | Put | SOLE | | 521,000 | 0 | 0 |
SAVARA INC | COM | 805111101 | 6,233,806 | 1,546,850 | SH | | SOLE | | 1,546,850 | 0 | 0 |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 190,477,000 | 350,000 | SH | Put | SOLE | | 350,000 | 0 | 0 |
SPDR SER TR | S&P BIOTECH | 78464A870 | 3,481,261 | 37,550 | SH | | SOLE | | 37,550 | 0 | 0 |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 2,636,862 | 69,999 | SH | | SOLE | | 69,999 | 0 | 0 |
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 12,070,504 | 513,420 | SH | | SOLE | | 513,420 | 0 | 0 |
TANGO THERAPEUTICS INC | COM | 87583X109 | 1,289,351 | 150,274 | SH | | SOLE | | 150,274 | 0 | 0 |
TECTONIC THERAPEUTIC INC | COM | 878972108 | 960,712 | 58,331 | SH | | SOLE | | 58,331 | 0 | 0 |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 23,562,500 | 1,450,000 | SH | | SOLE | | 1,450,000 | 0 | 0 |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 18,687,500 | 1,150,000 | SH | Call | SOLE | | 1,150,000 | 0 | 0 |
TWIST BIOSCIENCE CORP | COM | 90184D100 | 2,217,600 | 45,000 | SH | Call | SOLE | | 45,000 | 0 | 0 |
VAXCYTE INC | COM | 92243G108 | 4,530,600 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
VAXCYTE INC | COM | 92243G108 | 1,132,650 | 15,000 | SH | Call | SOLE | | 15,000 | 0 | 0 |
VERA THERAPEUTICS INC | CL A | 92337R101 | 13,567,500 | 375,000 | SH | | SOLE | | 375,000 | 0 | 0 |
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 10,122,000 | 700,000 | SH | | SOLE | | 700,000 | 0 | 0 |
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 1,780,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,951,500 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 1,871,250 | 375,000 | SH | | SOLE | | 375,000 | 0 | 0 |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 38,764,911 | 994,227 | SH | | SOLE | | 994,227 | 0 | 0 |
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 781,673 | 223,335 | SH | | SOLE | | 223,335 | 0 | 0 |
ZYMEWORKS INC | COM | 98985Y108 | 1,626,491 | 191,127 | SH | | SOLE | | 191,127 | 0 | 0 |